QURE Cash-Secured Put Strategy
QURE (uniQure N.V.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
QURE (uniQure N.V.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.82B, a beta of 0.87 versus the broader market, a 52-week range of 8.73-71.5, average daily share volume of 3.4M, a public-listing history dating back to 2014, approximately 209 full-time employees. These structural characteristics shape how QURE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.87 places QURE roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a cash-secured put on QURE?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current QURE snapshot
As of May 15, 2026, spot at $26.65, ATM IV 120.60%, IV rank 28.12%, expected move 34.57%. The cash-secured put on QURE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this cash-secured put structure on QURE specifically: QURE IV at 120.60% is on the cheap side of its 1-year range, which means a premium-selling QURE cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 34.57% (roughly $9.21 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated QURE expiries trade a higher absolute premium for lower per-day decay. Position sizing on QURE should anchor to the underlying notional of $26.65 per share and to the trader's directional view on QURE stock.
QURE cash-secured put setup
The QURE cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With QURE near $26.65, the first option leg uses a $25.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed QURE chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 QURE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $25.00 | $2.88 |
QURE cash-secured put risk and reward
- Net Premium / Debit
- +$287.50
- Max Profit (per contract)
- $287.50
- Max Loss (per contract)
- -$2,211.50
- Breakeven(s)
- $22.13
- Risk / Reward Ratio
- 0.130
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
QURE cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on QURE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$2,211.50 |
| $5.90 | -77.9% | -$1,622.36 |
| $11.79 | -55.7% | -$1,033.23 |
| $17.68 | -33.6% | -$444.09 |
| $23.58 | -11.5% | +$145.04 |
| $29.47 | +10.6% | +$287.50 |
| $35.36 | +32.7% | +$287.50 |
| $41.25 | +54.8% | +$287.50 |
| $47.14 | +76.9% | +$287.50 |
| $53.03 | +99.0% | +$287.50 |
When traders use cash-secured put on QURE
Cash-secured puts on QURE earn premium while a trader waits to acquire QURE stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning QURE.
QURE thesis for this cash-secured put
The market-implied 1-standard-deviation range for QURE extends from approximately $17.44 on the downside to $35.86 on the upside. A QURE cash-secured put lets a trader earn premium while waiting to acquire QURE at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current QURE IV rank near 28.12% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on QURE at 120.60%. As a Healthcare name, QURE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to QURE-specific events.
QURE cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. QURE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move QURE alongside the broader basket even when QURE-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on QURE carry tail risk when realized volatility exceeds the implied move; review historical QURE earnings reactions and macro stress periods before sizing. Always rebuild the position from current QURE chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on QURE?
- A cash-secured put on QURE is the cash-secured put strategy applied to QURE (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With QURE stock trading near $26.65, the strikes shown on this page are snapped to the nearest listed QURE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are QURE cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the QURE cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 120.60%), the computed maximum profit is $287.50 per contract and the computed maximum loss is -$2,211.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a QURE cash-secured put?
- The breakeven for the QURE cash-secured put priced on this page is roughly $22.13 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current QURE market-implied 1-standard-deviation expected move is approximately 34.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on QURE?
- Cash-secured puts on QURE earn premium while a trader waits to acquire QURE stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning QURE.
- How does current QURE implied volatility affect this cash-secured put?
- QURE ATM IV is at 120.60% with IV rank near 28.12%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.